Assembly Bio spikes after early-stage data for Gilead-partnered Hep B therapy
[ad_1]
Assembly Bio spikes after early-stage data for Gilead-partnered Hep B therapy
[ad_2]
Similar Posts
SA Charts: M&A snapshot of Paychex's deal to acquire Paycor in a $4.1B cash deal
Byadmin
[ad_1] SA Charts: M&A snapshot of Paychex's deal to acquire Paycor in a $4.1B cash deal [ad_2]
Apple, Google and Meta tech probes being reassessed in EU – report
Byadmin
[ad_1] Apple, Google and Meta tech probes being reassessed in EU – report [ad_2]
Sangamo plunges 38% after Pfizer ends agreement on hemophilia A gene therapy
Byadmin
[ad_1] Sangamo plunges 38% after Pfizer ends agreement on hemophilia A gene therapy [ad_2]
Snow Lake Resources drops 31%, prices $15 million offering (NASDAQ:LITM)
Byadmin
[ad_1] Snow Lake Resources (NASDAQ:LITM), doing business as Snow Lake Energy priced public offering of 18.75M shares at a public offering price of $0.80 per share. All of the shares in the offering are being offered by the company. Total gross proceeds are expected to be approximately $15M. The offering is expected to close on December 31,…
Trip.com Group to Emphasize Human Connection at SuperBridge Summit 2024
Byadmin
[ad_1] PRWire: In an era where digital connectivity transcends borders, Trip.com Group is set to highlight the enduring value of human interaction at the SuperBridge Summit 2024 in Dubai. Serving as the event’s title partner, the global travel services provider aims to share its innovative vision for the future of travel while empowering communities worldwide….
Azul and Abra to combine their businesses in Brazil
Byadmin
[ad_1] Azul and Abra to combine their businesses in Brazil [ad_2]